As of November 2024, United Therapeutics has a market cap of $16.10B. This makes United Therapeutics the world's 1051th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $10.07B | -2.57% |
2023 | $10.33B | -20.93% |
2022 | $13.07B | 28.70% |
2021 | $10.15B | 42.35% |
2020 | $7.13B | 72.33% |
2019 | $4.14B | -19.12% |
2018 | $5.12B | -26.39% |
2017 | $6.95B | 3.15% |
2016 | $6.74B | -8.42% |
2015 | $7.36B | 20.94% |
2014 | $6.09B | 14.51% |
2013 | $5.31B | 111.68% |
2012 | $2.51B | 13.06% |
2011 | $2.22B | -25.26% |
2010 | $2.97B | 20.08% |
2009 | $2.47B | 68.35% |
2008 | $1.47B | -35.94% |
2007 | $2.29B | 79.60% |
2006 | $1.28B | -21.34% |
2005 | $1.62B | 53.09% |
2004 | $1.06B | 96.73% |
2003 | $539.25M | 37.43% |
2002 | $392.40M | 60.42% |
2001 | $244.60M | -29.42% |
2000 | $346.58M | -67.93% |
1999 | $1.08B | - |